Significant Accounting Policies (Tables)

9 Months Ended

Jan. 31, 2023

Accounting Policies [Abstract]

Summary of antidilutive securities excluded from earnings per share calculations

The following table reflects the total potential share-based instruments outstanding at January 31, 2023 and 2022 including those that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive:

	January 31,
	2023	2022
Total common stock equivalents	1,779,167	1,681,448

Summary of the calculation of earnings (loss) per share, basic and diluted

	Three Months Ended January 31,				Nine Months Ended January 31,
(Dollars in Thousands)	2023		2022		2023		2022
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(2,439)	$	787	$	(2,774)	$	892
Weighted Average common shares – basic	13,558,642		13,500,444		13,532,990		13,170,880
Basic net income (loss) per share	$	(0.18)	$	0.06	$	(0.20)	$	0.07
Diluted net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	(2,439)	$	787	$	(2,774)	$	892
Weighted Average common shares	13,558,642		13,500,444		13,532,990		13,170,880
Incremental shares from assumed exercise of stock options	—		886,565		—		1,007,202
Adjusted weighted average share – diluted	13,558,642		14,387,009		13,532,990		14,178,082
Diluted net income (loss) per share	$	(0.18)	$	0.05	$	(0.20)	$	0.06